Meloxicam 15 mg tablets recalled for exposure to improper storage temperatures
Cardinal Healthcare is recalling Meloxicam 15 mg tablets nationwide due to exposure to temperatures outside labeled storage conditions. No adverse events have been reported.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: FDA Class II recall without reported illnesses or injuries. The hazard involves potential product degradation from temperature exposure during storage, making this a precautionary quality-control recall.
Plain-English summary
Cardinal Healthcare is recalling Meloxicam Tablets, USP, 15 mg (NDC 69097-159-15 and related package sizes) manufactured by Cipla Ltd. and distributed nationwide. The affected batch is KA11489.
The recall was initiated because the products were exposed to temperatures outside the labeled storage conditions during manufacturing. This deviation from proper storage requirements could affect the product's quality and stability.
Meloxicam is a nonsteroidal anti-inflammatory drug (NSAID) prescribed to treat pain and inflammation. No illnesses or injuries have been reported in connection with this recall.
Patients who have this medication should contact their healthcare provider or pharmacist if they have questions about whether their medication is affected or if they need to take any action.
The recalled product
- Product
- MELOXICAM (MELOXICAM)
- Brand
- MELOXICAM
- Manufacturer
- CARDINAL HEALTHCARE
- Affected units
- 1
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- Batch KA11489
UPCs (2)
- 0369097159078
- 0369097158071
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 42 recalled by CARDINAL HEALTHCARE under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 42 products in this recall →Related recalls
Same brand · MELOXICAM
- ModerateCardinal Health Recalls Meloxicam Tablets Due to Temperature Excursions
FDA (Drugs) · 2021-06-02
Same manufacturer · CARDINAL HEALTHCARE
See all →- HighAlbuterol Sulfate Inhaler Recalled Due to Temperature Storage Deviation
FDA (Drugs) · 2024-01-03
- HighPredniSONE Tablets Recalled for Temperature Storage Deviation
FDA (Drugs) · 2024-01-03
- HighLow-dose aspirin recall due to improper storage temperature conditions
FDA (Drugs) · 2024-01-03
- HighBumetanide Tablets Recalled for Exposure to Improper Storage Temperatures
FDA (Drugs) · 2024-01-03
- HighLithium Carbonate Extended-Release Tablets Recalled for Temperature Excursion
FDA (Drugs) · 2024-01-03
Same hazard · temperature exposure
See all →- ModerateQuantimetrix Urine Chemistry Control Set Recalled for Temperature Exposure
FDA (Devices) · 2024-10-30
- ModerateAllopurinol tablets recalled due to improper storage conditions
FDA (Drugs) · 2024-01-03
- HighAmoxicillin tablets recalled due to improper storage temperature exposure
FDA (Drugs) · 2024-01-03
- HighRespiratory inhalation medication recalled for temperature storage deviation
FDA (Drugs) · 2024-01-03
- HighRivastigmine Transdermal Patch Recalled Due to Temperature Exposure
FDA (Drugs) · 2024-01-03